Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa GelRecruiting
NCT07698886Phase 2Updated Aug 21, 2026
Sponsor: KTH Biopharma
HPV (Human Papillomavirus)-Associated · Genital Warts
Vietnam
The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-RadiationRecruiting
NCT06843551Phase 2Updated Aug 21, 2026
Sponsor: Benjamin Spieler
Metastatic Pancreatic Ductal Adenocarcinoma · Metastatic Pancreatic Cancer
United States
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back PainRecruiting
NCT07641504Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Chronic Pain · Low Back Pain
United States, Puerto Rico
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's DiseaseRecruiting
NCT07378644Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Skyhawk Therapeutics, Inc.
Huntington Disease
United States, Argentina, Brazil, Canada, Chile +2 more
Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory NeuroblastomaRecruiting
NCT07767630EARLY_Phase 1Updated Aug 21, 2026
Sponsor: Sichuan University
Neuroblastoma (NB)
China
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKDRecruiting
NCT06110130Phase 4Updated Aug 21, 2026
Sponsor: Washington D.C. Veterans Affairs Medical Center
Chronic Kidney Diseases
United States
Deciphering the Genetic Architecture of Autoimmune DiseasesRecruiting
NCT06948110N/AUpdated Aug 21, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Autoimmune Diseases
United States, Peru
A Study of Eptinezumab in Pediatric Participants With Episodic MigraineRecruiting
NCT05897320Phase 3Updated Aug 21, 2026
Sponsor: H. Lundbeck A/S
Episodic Migraine
United States, Argentina, Canada, Italy, Mexico +6 more
CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line TherapyRecruiting
NCT07779018Phase 2Updated Aug 21, 2026
Sponsor: Liping Dou
Lymphoma
China
Comparing the Effects of Newer Pacemakers and Their Effects on the Heart and Valve Function in the Short-term.Recruiting
NCT07534917N/AUpdated Aug 21, 2026
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Pacemaker-Induced Cardiomyopathy · Tricuspid Regurgitation · Right Ventricular Dysfunction
United Kingdom
PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.Recruiting
NCT06369246Phase 2Updated Aug 21, 2026
Sponsor: M.D. Anderson Cancer Center
Advanced Prostate Cancer
United States
Genetic of Skeletal Muscle Insulin ResistanceRecruiting
NCT07780513NAUpdated Aug 21, 2026
Sponsor: The University of Texas Health Science Center at San Antonio
Insulin Stimulated
United States
Developing Transcranial Neuromodulation Protocols for Learning and Decision-MakingRecruiting
NCT06561828EARLY_Phase 1Updated Aug 21, 2026
Sponsor: National Institute on Drug Abuse (NIDA)
Normal Physiology
United States
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)Recruiting
NCT07169630Phase 1Updated Aug 21, 2026
Sponsor: National Institute of Mental Health (NIMH)
Alzheimer s Disease · Mild Cognitive Impairment · Healthy
United States
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting
NCT07165028Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Metabolic Dysfunction-Associated Steatotic Liver Disease
United States, Argentina, Australia, Austria, Belgium +29 more
A Study of E6742 in Participants With Systemic Lupus ErythematosusRecruiting
NCT07515014Phase 2Updated Aug 21, 2026
Sponsor: Eisai Co., Ltd.
Systemic Lupus Erythematosus
China, Japan, South Korea, Taiwan
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruiting
NCT06575426Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Otsuka Pharmaceutical Factory, Inc.
Diabetes Mellitus, Type 1 · Hypoglycemia · Islet Cell Transplantation · Type 1 Diabetes
United States
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsRecruiting
NCT07109726Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Terremoto Biosciences Inc.
Breast Cancer · Endometrial Cancer · Ovarian Cancer · Lung Squamous Cell Carcinoma
United States, Puerto Rico
Passive Fit of Implant-Supported Frameworks: Digital vs Conventional ImpressionsRecruiting
NCT07778199NAUpdated Aug 21, 2026
Sponsor: Mansoura University
Dental Implants · Edentulous Jaw · Passive Fit
Egypt
NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid TumorsRecruiting
NCT07489378N/AUpdated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Very Rare Tumors · Very Rare Cancers · Other Solid Tumors · Solid Tumor
United States
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Recruiting
NCT07621718Phase 3Updated Aug 21, 2026
Sponsor: Revolution Medicines, Inc.
Pancreatic Cancer · Pancreatic Cancer Metastatic · PDAC · PDAC - Pancreatic Ductal Adenocarcinoma
United States
Individualized AML TreatmentRecruiting
NCT07613385N/AUpdated Aug 21, 2026
Sponsor: City of Hope Medical Center
Relapsed/Refractory Acute Myeloid Leukemia (AML)
United States
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic MigraineRecruiting
NCT04965675Phase 3Updated Aug 21, 2026
Sponsor: H. Lundbeck A/S
Chronic Migraine in Children
United States, Argentina, Canada, Italy, Mexico +6 more
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)Recruiting
NCT07531095Phase 1Updated Aug 21, 2026
Sponsor: Amgen
Small Cell Lung Cancer
United States, Australia, Belgium, France, Germany +4 more
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate VaccinesRecruiting
NCT07135453Phase 4Updated Aug 21, 2026
Sponsor: University of Alabama at Birmingham
Vaccine · Pneumococcal Disease
United States

Previous page Next page